Mostrar o rexistro simple do ítem
Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes
dc.contributor.author | Oftedal, B.E. | * |
dc.contributor.author | Assing, K. | * |
dc.contributor.author | Baris, S. | * |
dc.contributor.author | Safgren, S.L. | * |
dc.contributor.author | Johansen, I.S. | * |
dc.contributor.author | Jakobsen, M.A. | * |
dc.contributor.author | Babovic-Vuksanovic, D. | * |
dc.contributor.author | Agre, K. | * |
dc.contributor.author | Klee, E.W. | * |
dc.contributor.author | Majcic, E. | * |
dc.contributor.author | Ferré, E.M.N. | * |
dc.contributor.author | Schmitt, M.M. | * |
dc.contributor.author | DiMaggio, T. | * |
dc.contributor.author | Rosen, L.B. | * |
dc.contributor.author | Rahman, M.O. | * |
dc.contributor.author | Chrysis, D. | * |
dc.contributor.author | Giannakopoulos, A. | * |
dc.contributor.author | Tallón García, María | * |
dc.contributor.author | González-Granado, L.I. | * |
dc.contributor.author | Stanley, K. | * |
dc.contributor.author | Galant-Swafford, J. | * |
dc.contributor.author | Suwannarat, P. | * |
dc.contributor.author | Meyts, I. | * |
dc.contributor.author | Lionakis, M.S. | * |
dc.contributor.author | Husebye, E.S. | * |
dc.date.accessioned | 2025-09-09T10:22:28Z | |
dc.date.available | 2025-09-09T10:22:28Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Oftedal BE, Assing K, Baris S, Safgren SL, Johansen IS, Jakobsen MA, et al. Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes. iScience. 2023;26(6). | |
dc.identifier.issn | 2589-0042 | |
dc.identifier.other | https://portalcientifico.sergas.gal//documentos/647346cec0b3b13849988251 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/21366 | |
dc.description.abstract | Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive disease characterized by severe and childhood onset organ-specific autoimmunity caused by mutations in the autoimmune regulator (AIRE) gene. More recently, dominant-negative mutations within the PHD1, PHD2, and SAND domains have been associated with an incompletely penetrant milder phenotype with later onset familial clustering, often masquerading as organ-specific autoimmunity. Patients with immunodeficiencies or autoimmunity where genetic analyses revealed heterozygous AIRE mutations were included in the study and the dominant-negative effects of the AIRE mutations were functionally assessed in vitro. We here report additional families with phenotypes ranging from immunodeficiency, enteropathy, and vitiligo to asymptomatic carrier status. APS-1-specific autoantibodies can hint to the presence of these pathogenic AIRE variants although their absence does not rule out their presence. Our findings suggest functional studies of heterozygous AIRE variants and close follow-up of identified individuals and their families. | |
dc.description.sponsorship | We would like to thank Dr. Morten Bagge Hansen for the measurements of autoantibodies to: IFN-g, IL -1a, IL -6, and TNF-a. We would like to thank Elisabeth Halvorsen for technical help at the University of Bergen. B.E.O. is funded by Novo Nordic Foundation, grant number NNF21OC0067918 and the Regional Health authorities of Western Norway. I.M. isa senior clinical investigator at FWO Vlaanderen and is funded by the Jeffrey Modell Foundation and by the KU Leuven C1 Grant C16/18/007. The work was supported, in part, by the Division of Intramural Research (DIR) of the NIAID/NIH. | |
dc.language | eng | |
dc.rights | Attribution 4.0 International (CC BY 4.0) | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes | |
dc.type | Artigo | |
dc.authorsophos | Oftedal, B.E.; Assing, K.; Baris, S.; Safgren, S.L.; Johansen, I.S.; Jakobsen, M.A.; Babovic-Vuksanovic, D.; Agre, K.; Klee, E.W.; Majcic, E.; Ferré, E.M.N.; Schmitt, M.M.; DiMaggio, T.; Rosen, L.B.; Rahman, M.O.; Chrysis, D.; Giannakopoulos, A.; Garcia, M.T.; González-Granado, L.I.; Stanley, K.; Galant-Swafford, J.; Suwannarat, P.; Meyts, I.; Lionakis, M.S.; Husebye, E.S. | |
dc.identifier.doi | 10.1016/j.isci.2023.106818 | |
dc.identifier.sophos | 647346cec0b3b13849988251 | |
dc.issue.number | 6 | |
dc.journal.title | iScience | * |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Vigo::Pediatría | |
dc.relation.projectID | Novo Nordic Foundation [NNF21OC0067918] | |
dc.relation.projectID | Regional Health authorities of Western Norway | |
dc.relation.projectID | Jeffrey Modell Foundation | |
dc.relation.projectID | KU Leuven C1 Grant [C16/18/007] | |
dc.relation.projectID | Division of Intramural Research (DIR) of the NIAID/NIH | |
dc.relation.publisherversion | https://doi.org/10.1016/j.isci.2023.106818 | |
dc.rights.accessRights | openAccess | * |
dc.subject.keyword | AS Vigo | |
dc.subject.keyword | CHUVI | |
dc.typefides | Artículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis) | |
dc.typesophos | Artículo Original | |
dc.volume.number | 26 |
Ficheiros no ítem
Este ítem aparece na(s) seguinte(s) colección(s)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution 4.0 International (CC BY 4.0)
